Hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic ...

Precision BioSciences (NASDAQ:DTIL) added ~6% in the premarket on Wednesday after the gene therapy developer announced initial safety and efficacy data from an early-stage trial for its Hepatitis ...

Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related conditions that ...

ADMA Biologics (NASDAQ:ADMA – Get Free Report)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a report released on Tuesday,Benzinga reports. They currently have a ...

Protein vaccines are composed of purified or recombinant proteinaceous antigens from a pathogen ... Effectiveness of the hepatitis E vaccine HEV 239 amongst high-risk groups isn’t well studied.

Enzyme-linked immunosorbent assay (ELISA) was used to detect hepatitis E virus antigen (HEV-Ag), antibodies (HEV-IgG, HEV-IgM). Single-person nucleic acid testing for HEV RNA was performed on samples ...

European Commission approves Bristol Myers Squibb’s Opdivo plus Yervoy for first-line treatment of adult patients with unresectable or advanced HCC: Princeton, New Jersey Monday ...

Law enforcement officers often request or demand that Idaho hospitals draw blood or conduct other tests on patients for law ...

Objective Hepatitis E virus (HEV), one of the most common agent of acute hepatitis ... HEV virions also infected intestinal tissue explants. Lastly, HEV RNA and antigen were detected in the intestinal ...